RecruitingNCT05524298
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma Treated With Immunotherapy Or Immunochemotherapy And/Or Radiotherapy: An Observational Prospective Study Of The Fondazione Italiana Linfomi
Sponsor
Fondazione Italiana Linfomi - ETS
Enrollment
150 participants
Start Date
Dec 7, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
Aims of this study are to describe the variation of QoL (Quality of Life) during the clinical management of low-grade lymphoma in elderly subjects and to identify the most important factors at diagnosis and during treatment with an impact on QoL (Quality of Life).
Eligibility
Min Age: 70 Years
Inclusion Criteria7
- Local histological diagnosis of indolent B cell non-Hodgkin lymphoma: follicular lymphoma, marginal zone lymphoma (nodal, MALT (Mucosa-Associated Lymphoid Tissue), splenic), lymphoplasmacytic lymphoma/ Waldenström macroglobulinemia)
- Age ≥ 70 years
- Patient candidates to receive treatment for lymphoma
- Patient previously untreated for lymphoma
- Evaluation of Comprehensive Geriatric Assessment at baseline
- Ability to provide informed consent: subject understands and voluntarily signs an informed consent form approved by an IEC (Independent Ethics Committee), prior to registration into the study
- Note: Patient treated in the context of a clinical trial is admitted
Exclusion Criteria1
- none
Locations(20)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05524298